Our Profile

At Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere. We ensure a tight connection from research to development to commercialization to rapidly meet the needs of the cancer community, optimizing our ability to bring transformative medicines to patients. Our demonstrated leadership in the treatment of hematologic cancers and solid tumors combined with cutting-edge science through multiple platforms, partnerships and therapeutic approaches enable us to bring novel medicines to cancer patients worldwide.

Takeda Oncology, the Global Oncology Business Unit of Takeda Pharmaceutical Company, is headquartered in Cambridge, Massachusetts

• Takeda Oncology has hubs in 10 countries; United States, Japan, Germany, Spain & Portugal, France, Italy, the United Kingdom/Ireland and Canada
• Our R&D center is in Cambridge, MA, United States
• Our manufacturing centers are in five countries: Ireland, Austria, Russia, Japan and United States